trial · primary record
JNJ-101556143 Formulation 1
Metastatic Prostate Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 190 |
| Primary completion | 2028-08-17 |
| Primary endpoint | Frequency of dose-limiting toxicities (DLTs) |
| Registry ID | NCT06800313 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:58.529Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06800313
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.